Kura Oncology, Inc.’s Post

For the fourth year in a row, #TeamKura was honored to support TeamNEGU: Never Ever Give Up! at their annual #JoyJars event in San Diego and Boston.    NEGU’s vision is to become a symbol of help and hope in the childhood cancer space so every child fighting cancer (and their families) have the support and encouragement to #NEGU during their courageous fight.    We're proud to join NEGU in their mission to spread joy and encourage every kid fighting cancer to Never Ever Give Up! 

Could #menin be the key to understanding the development of NPM1-m and KMT2A-r #AML? While menin is known for its multiple functions, it plays a crucial role in regulating gene expression. Emerging research indicates that activation of the menin pathway may significantly impact the development of NPM1-m and KMT2A-r AML, unlocking new insights into the complexities of AML. Kura Oncology is investigating the potential of menin inhibition with #ziftomenib in patients with AML. See ongoing clinical trials: https://bit.ly/3A2vZL1 

At #FierceJPM Week, CEO Troy Wilson, Ph.D., J.D. gave his insights on the Inflation Reduction Act (#IRA), including how we can move forward in the best interest of patients.     Hear more in the clip below and view more highlights from the panel here: https://lnkd.in/g8FgCRCD  

Congratulations to our very own Chief Operating Officer Kathy Ford for being named in the 2024 PharmaVoice 100 list!     This prestigious award recognizes the top 100 influential industry leaders who are devoted to lifting the pillars of #biotech and drug development to new heights. Join us in congratulating Kathy on her accomplishment!    See the full list here: https://bit.ly/4gQi6Ah 

This #HispanicHeritageMonth, we reflect on the remarkable contributions of Hispanic leaders in #biotech and beyond.    At Kura, we are proud of the diverse talent that fuels our success. Hear more from #TeamKura member Alma Ortiz on our commitment to inclusivity.     #HHM24 

#TeamKura is proud to join the The Leukemia & Lymphoma Society for our 4th consecutive #LighttheNight event! Together, we're bringing light to the darkness of cancer by supporting groundbreaking research and bringing hope to patients and families battling blood cancers. Join us as we walk to celebrate, honor, and remember those affected.   Find a Light the Night walk near you and help shine a light in the fight against blood cancer! https://lnkd.in/dFqbRn8 #LLSUSA

At Kura, we believe in cultivating an environment where every voice is heard, nurtured, and valued.    This #GlobalDiversityAwarenessMonth, we’re honored to highlight our ongoing partnership with Life Science Cares San Diego and Life Science Cares Boston. Through our mutual collaboration, we provide underrepresented students the tools and experiences to pursue a career in #STEM. By removing barriers and creating growth opportunities, we’re hoping to build a more diverse workforce that will drive the next wave of scientific breakthroughs.     Thank you to Life Science Cares for your continued efforts to build equity and inclusion for all!     #GlobalDiversityAwarenessMonth  

Data from our KOMET-001 Phase 1 study has been published in The Lancet Oncology journal! Learn more about the clinical data and what it means for ziftomenib’s potential in relapsed or refractory (R/R) NPM1-mutant acute myeloid leukemia (#AML): https://bit.ly/3XFaYO8 

On #RareCancerDay, September 30, join Kura Oncology in showing support for patients, clinicians, and scientists fighting rare cancers. Despite >500 types of rare cancers, fewer than 40,000 people are affected annually. With fewer patients, rare cancers can be hard to study, treat, and cure. Through its ongoing clinical trial programs, Kura Oncology is exploring new therapies designed to address rare cancer challenges. Learn about our clinical trial programs in head and neck cancer, lung cancer, and acute leukemias: https://bit.ly/4earkWd

Our Chief Commercial Officer, Brian Powl, will join a panel discussion around best practices for effective drug launch planning at the 2024 Fierce New Product Planning Summit in Boston next week. Here, he will share his insights from his experience across pharma and biotechnology companies.   Learn more: https://sched.co/1ehzT    Fierce Life Sciences Events | #FierceNPP